Authors: Goldstein, DJ Offen, WW Klein, EG Phebus, LA Hipskind, P Johnson, KW Ryan, RE

Citation: Dj. Goldstein et al., Lanepitant, an NK-1 antagonist, in migraine prevention, CEPHALALGIA, 21(2), 2001, pp. 102-106

Authors: Goldstein, DJ Roon, KI Offen, WW Ramadan, NM Phebus, LA Johnson, KW Schaus, JM Ferrari, MD

Citation: Dj. Goldstein et al., Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial, LANCET, 358(9289), 2001, pp. 1230-1234

Authors: Du, YS Ma, ZZ Lin, SZ Dodel, RC Gao, F Bales, KR Triarhou, LC Chernet, E Perry, KW Nelson, DLG Luecke, S Phebus, LA Bymaster, FP Paul, SM

Citation: Ys. Du et al., Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease, P NAS US, 98(25), 2001, pp. 14669-14674

Authors: Xu, YC Johnson, KW Phebus, LA Cohen, M Nelson, DL Schenck, K Walker, CD Fritz, JE Kaldor, SW LeTourneau, ME Murff, RE Zgombick, JM Calligaro, DO Audia, JE Schaus, JM

Citation: Yc. Xu et al., N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy, J MED CHEM, 44(24), 2001, pp. 4031-4034